title: 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
authors.forename: M
authors.initials: M
authors.lastname: Toubeau
authors.forename: C
authors.initials: C
authors.lastname: Touzery
authors.forename: A
authors.initials: A
authors.lastname: Berriolo-Riedinger
authors.forename: A
authors.initials: A
authors.lastname: Cochet
authors.forename: F
authors.initials: F
authors.lastname: Brunotte
authors.forename: L
authors.initials: L
authors.lastname: Bedenne
authors.forename: J P
authors.initials: JP
authors.lastname: Cercueil
authors.forename: D
authors.initials: D
authors.lastname: Krause
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007459:Iodized Oil / Q000008:administration & dosage / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000378:metabolism*
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D007459:Iodized Oil